Stakeholder views of managed entry agreements: A literature review of national studies
Access to highly expensive and innovative medicine is a challenge. Managed entry agreements/ arrangements (MEAs) consist of various forms of confidential agreements between pharmaceutical manufacturers and payers (hospitals, social insurance), which are mainly negotiated when there is uncertainty of...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-12-01
|
| Series: | Health Policy Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590229621000034 |